Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID Reference newsletter

Breast Cancer

Free Subscription 19.10.2020 1 Am J Epidemiol 1 Ann Oncol 1 Ann Surg Oncol 2 BMC Cancer 2 Breast Cancer 2 Breast Cancer Res Treat 3 Breast J 1 Cancer Cell 1 Cancer Lett 1 Clin Breast Cancer 1 Eur J Surg Oncol 1 J Nucl Med 3 J Surg Oncol 1 Oncogene 1 Radiology 1 Semin Oncol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Epidemiol

1. SEIGNEURIN A, Exbrayat C, Molinie F, Croisier L, et al
   Reduction of breast cancer mortality associated with mammography screening: a modelling study using population-based data from 2 French departements.
   Am J Epidemiol. 2020 Oct 12. pii: 5920863. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Ann Oncol

2. STECKLEIN SR, Sharma P
   Last but not Least: Antibody-Drug Conjugates in Hormone Receptor-Positive Metastatic Breast Cancer.
   Ann Oncol. 2020 Oct 7. pii: S0923-7534(20)42492.
   PubMed        
   
   

   
   Ann Surg Oncol

3. ISHITOBI M, Hayashi N
   ASO Author Reflections: What will be Required to Safely Omit Breast Surgery for Early-Stage Breast Cancer?
   Ann Surg Oncol. 2020 Oct 12. pii: 10.1245/s10434-020-09195.
   PubMed        
   
   

   
   BMC Cancer

4. ZHAO W, Wu L, Zhao A, Zhang M, et al
   A nomogram for predicting survival in patients with de novo metastatic breast cancer: a population-based study.
   BMC Cancer. 2020;20:982.
   PubMed         Abstract available
   
   
5. LI X, Zhou C, Wu Y, Chen X, et al
   Relationship between formulaic breast volume and risk of breast cancer based on linear measurements.
   BMC Cancer. 2020;20:989.
   PubMed         Abstract available
   
   

   
   Breast Cancer

6. LAO C, Kuper-Hommel M, Elwood M, Campbell I, et al
   Characteristics and survival of de novo and recurrent metastatic breast cancer in New Zealand.
   Breast Cancer. 2020 Oct 12. pii: 10.1007/s12282-020-01171.
   PubMed         Abstract available
   
   
7. LING Y, Cao Q, Liu Y, Zhao J, et al
   Profilin 2 (PFN2) promotes the proliferation, migration, invasion and epithelial-to-mesenchymal transition of triple negative breast cancer cells.
   Breast Cancer. 2020 Oct 12. pii: 10.1007/s12282-020-01169.
   PubMed         Abstract available
   
   

   
   Breast Cancer Res Treat

8. BEN-ZION BERLINER M, Yerushalmi R, Lavie I, Benouaich-Amiel A, et al
   Central nervous system metastases in breast cancer: the impact of age on patterns of development and outcome.
   Breast Cancer Res Treat. 2020 Oct 10. pii: 10.1007/s10549-020-05959.
   PubMed         Abstract available
   
   
9. TURNBULL AK, Patel S, Martinez-Perez C, Rigg A, et al
   Risk of chemotherapy-related amenorrhoea (CRA) in premenopausal women undergoing chemotherapy for early stage breast cancer.
   Breast Cancer Res Treat. 2020 Oct 12. pii: 10.1007/s10549-020-05951.
   PubMed         Abstract available
   
   

   
   Breast J

10. BEKENY JC, Schreeder CA, Wirth P, Luvisa K, et al
    Factors contributing to persistent rates of contralateral prophylactic mastectomy in breast cancer patients: Examination of 1051 mastectomies across a single health system.
    Breast J. 2020 Oct 9. doi: 10.1111/tbj.14080.
    PubMed         Abstract available
    
    
11. DE GIORGI V, Venturi F, Portelli F, Maida P, et al
    Eyelid skin metastasis as first sign of breast cancer recurrence.
    Breast J. 2020 Oct 9. doi: 10.1111/tbj.14077.
    PubMed        
    
    
12. ANDERSON SR, Tuttle RM, Markov LCNP, Johnson RM, et al
    The surgical treatment of breast cancer: A journey, not a procedure.
    Breast J. 2020 Oct 11. doi: 10.1111/tbj.14081.
    PubMed        
    
    

    
    Cancer Cell

13. HILLIS AL, Toker A
    Lactate Lights up PI3K Inhibitor Resistance in Breast Cancer.
    Cancer Cell. 2020;38:441-443.
    PubMed         Abstract available
    
    

    
    Cancer Lett

14. DUTTA I, Dieters-Castator D, Papatzimas JW, Medina A, et al
    ADAM protease inhibition overcomes resistance of breast cancer stem-like cells to gammadelta T cell immunotherapy.
    Cancer Lett. 2020 Oct 9. pii: S0304-3835(20)30535.
    PubMed         Abstract available
    
    

    
    Clin Breast Cancer

15. HAYASHI N, Yagata H, Tsugawa K, Kajiura Y, et al
    Response and Prognosis of Docetaxel and Cyclophosphamide as Neoadjuvant Chemotherapy in ER(+) HER2(-) Breast Cancer: A Prospective Phase II Study.
    Clin Breast Cancer. 2020 Sep 18. pii: S1526-8209(20)30233.
    PubMed         Abstract available
    
    

    
    Eur J Surg Oncol

16. MORGAN JL, Holmes G, Ward S, Martin C, et al
    Observational cohort study to determine the degree and causes of variation in the rate of surgery or primary endocrine therapy in older women with operable breast cancer.
    Eur J Surg Oncol. 2020 Sep 30. pii: S0748-7983(20)30801.
    PubMed         Abstract available
    
    

    
    J Nucl Med

17. VIDAL-SICART S, Rioja ME, Prieto A, Goni E, et al
    Sentinel Lymph Node Biopsy in breast cancer with (99m)Tc-Tilmanocept: A novel tracer in the real life. A multicenter study.
    J Nucl Med. 2020 Oct 9. pii: jnumed.120.252064. doi: 10.2967/jnumed.120.252064.
    PubMed         Abstract available
    
    

    
    J Surg Oncol

18. FRASSON AL, Resende HM, Lichtenfels M, Barbosa F, et al
    Axillary management for patients with breast cancer after neoadjuvant chemotherapy: Results of a survey among Brazilian breast surgeons.
    J Surg Oncol. 2020 Jul 7. doi: 10.1002/jso.26104.
    PubMed         Abstract available
    
    
19. CORSO G, Frassoni S, Girardi A, De Camilli E, et al
    Metaplastic breast cancer: Prognostic and therapeutic considerations.
    J Surg Oncol. 2020 Oct 12. doi: 10.1002/jso.26248.
    PubMed         Abstract available
    
    
20. LI X, Tan Q, Li H, Yang X, et al
    Predictive value of tumor-infiltrating lymphocytes for response to neoadjuvant chemotherapy and breast cancer prognosis.
    J Surg Oncol. 2020 Oct 12. doi: 10.1002/jso.26252.
    PubMed         Abstract available
    
    

    
    Oncogene

21. ZHANG L, Qin Y, Wu G, Wang J, et al
    PRRG4 promotes breast cancer metastasis through the recruitment of NEDD4 and downregulation of Robo1.
    Oncogene. 2020 Oct 9. pii: 10.1038/s41388-020-01494.
    PubMed         Abstract available
    
    

    
    Radiology

22. ZUCKERMAN SP, Sprague BL, Weaver DL, Herschorn SD, et al
    Multicenter Evaluation of Breast Cancer Screening with Digital Breast Tomosynthesis in Combination with Synthetic versus Digital Mammography.
    Radiology. 2020 Oct 13:200240. doi: 10.1148/radiol.2020200240.
    PubMed         Abstract available
    
    

    
    Semin Oncol

23. CASAVILCA-ZAMBRANO S, Custodio N, Liendo-Picoaga R, Cancino-Maldonado K, et al
    Depression in women with a diagnosis of breast cancer. Prevalence of symptoms of depression in Peruvian women with early breast cancer and related sociodemographic factors.
    Semin Oncol. 2020 Sep 4. pii: S0093-7754(20)30090.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: